Published in J Comput Aided Mol Des on August 01, 2003
Virtual screening of chemical libraries. Nature (2004) 4.84
Empirical entropic contributions in computational docking: evaluation in APS reductase complexes. J Comput Chem (2008) 2.59
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design. J Comput Aided Mol Des (2008) 2.16
Target flexibility: an emerging consideration in drug discovery and design. J Med Chem (2008) 1.74
Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J Mol Biol (2008) 1.57
Probing molecular docking in a charged model binding site. J Mol Biol (2006) 1.17
Docking for fragment inhibitors of AmpC beta-lactamase. Proc Natl Acad Sci U S A (2009) 1.13
Binding of myotrophin/V-1 to actin-capping protein: implications for how capping protein binds to the filament barbed end. J Biol Chem (2006) 1.09
Docking screens: right for the right reasons? Curr Top Med Chem (2009) 1.05
Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. J Med Chem (2009) 1.03
Binding site and affinity prediction of general anesthetics to protein targets using docking. Anesth Analg (2012) 1.01
p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. J Mol Biol (2009) 1.00
Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites. Biochemistry (2012) 0.98
Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41. Bioorg Med Chem Lett (2010) 0.88
Calculations of protein-ligand binding entropy of relative and overall molecular motions. J Comput Aided Mol Des (2007) 0.88
A new peptide docking strategy using a mean field technique with mutually orthogonal Latin square sampling. J Comput Aided Mol Des (2008) 0.88
Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol (2007) 0.87
Solution structure and function of YndB, an AHSA1 protein from Bacillus subtilis. Proteins (2010) 0.86
Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc (2016) 0.86
Evaluation of an inverse molecular design algorithm in a model binding site. Proteins (2009) 0.85
Application of consensus scoring and principal component analysis for virtual screening against β-secretase (BACE-1). PLoS One (2012) 0.84
6-Shogaol induces apoptosis in human leukemia cells through a process involving caspase-mediated cleavage of eIF2α. Mol Cancer (2013) 0.81
Evaluation of different virtual screening programs for docking in a charged binding pocket. J Chem Inf Model (2008) 0.80
Discovery of fragment molecules that bind the human peroxiredoxin 5 active site. PLoS One (2010) 0.79
Sequence analysis and homology modeling of peroxidase from Medicago sativa. Bioinformation (2012) 0.78
Molecular docking studies of protein-nucleotide complexes using MOLSDOCK (mutually orthogonal Latin squares DOCK). J Mol Model (2012) 0.77
Multiple ligand-binding modes in bacterial R67 dihydrofolate reductase. J Comput Aided Mol Des (2005) 0.76
Interactions of non-natural halogenated substrates with D-specific dehalogenase (DehD) mutants using in silico studies. Biotechnol Biotechnol Equip (2014) 0.76
Homology modeling of the structure of acyl coA:isopenicillin N-acyltransferase (IAT) from Penicillium chrysogenum. IAT interaction studies with isopenicillin-N, combining molecular dynamics simulations and docking. J Mol Model (2011) 0.75
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit (1996) 6.51
Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J Comput Aided Mol Des (1996) 5.09
Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins (2002) 2.70
Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. J Biol Chem (1984) 2.56
Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem Biol (1996) 2.21
Identification by ENDOR of Trp191 as the free-radical site in cytochrome c peroxidase compound ES. Science (1989) 2.02
Ligand solvation in molecular docking. Proteins (1999) 1.65
Small molecule binding to an artificially created cavity at the active site of cytochrome c peroxidase. Biochemistry (1994) 1.18
Histidine 52 is a critical residue for rapid formation of cytochrome c peroxidase compound I. Biochemistry (1993) 1.15
The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins (1999) 1.11
Comprehensive explanation of the anomalous EPR spectra of wild-type and mutant cytochrome c peroxidase compound ES. Biochemistry (1993) 1.09
Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein. J Mol Biol (2002) 1.08
Computational studies of the interaction of myoglobin and xenon. J Mol Biol (1986) 1.08
Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm. J Mol Biol (1997) 1.07
A ligand-gated, hinged loop rearrangement opens a channel to a buried artificial protein cavity. Nat Struct Biol (1996) 1.06
Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol (2002) 1.03
Modelling of factor Xa-inhibitor complexes: a computational flexible docking approach. Proteins (1999) 1.01
Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C? J Med Chem (2000) 1.01
Conserved water molecules in MHC class-I molecules and their putative structural and functional roles. Protein Eng (2002) 1.00
Introduction of novel substrate oxidation into cytochrome c peroxidase by cavity complementation: oxidation of 2-aminothiazole and covalent modification of the enzyme. Biochemistry (1997) 0.98
The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: heat-labile enterotoxin, a multivalent test case. J Med Chem (1999) 0.94
The role of aspartate-235 in the binding of cations to an artificial cavity at the radical site of cytochrome c peroxidase. Protein Sci (1995) 0.90
Automated docking of ligands to antibodies: methods and applications. Methods (2000) 0.87
Conformational changes in nitric oxide synthases induced by chlorzoxazone and nitroindazoles: crystallographic and computational analyses of inhibitor potency. Biochemistry (2002) 0.84
Automated docking and the search for HIV protease inhibitors. SAR QSAR Environ Res (1998) 0.83
Automated docking of maltose, 2-deoxymaltose, and maltotetraose into the soybean beta-amylase active site. Proteins (1999) 0.80
The cannabinoid receptor: computer-aided molecular modeling and docking of ligand. J Mol Graph Model (1997) 0.77
Automated docking of monosaccharide substrates and analogues and methyl alpha-acarviosinide in the glucoamylase active site. Proteins (1997) 0.77
Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment. J Comput Aided Mol Des (1999) 0.75
Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4) J Med Chem (1996) 0.75
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem (2010) 25.20
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem (2009) 23.19
A semiempirical free energy force field with charge-based desolvation. J Comput Chem (2007) 8.40
The RCSB Protein Data Bank: redesigned web site and web services. Nucleic Acids Res (2010) 7.68
The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res (2012) 5.73
Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries. J Chem Inf Model (2007) 2.71
Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins (2002) 2.70
Empirical entropic contributions in computational docking: evaluation in APS reductase complexes. J Comput Chem (2008) 2.59
The cAMP binding domain: an ancient signaling module. Proc Natl Acad Sci U S A (2004) 2.32
Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics (2008) 1.94
Target flexibility: an emerging consideration in drug discovery and design. J Med Chem (2008) 1.74
Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design. J Am Chem Soc (2007) 1.65
Inhibitors of HIV-1 protease by using in situ click chemistry. Angew Chem Int Ed Engl (2006) 1.63
Visualizing biological data-now and in the future. Nat Methods (2010) 1.61
High-resolution crystal structures and spectroscopy of native and compound I cytochrome c peroxidase. Biochemistry (2003) 1.44
Tactile teaching: Exploring protein structure/function using physical models*. Biochem Mol Biol Educ (2006) 1.43
Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J Mol Biol (2009) 1.39
Visualization of macromolecular structures. Nat Methods (2010) 1.34
ePMV embeds molecular modeling into professional animation software environments. Structure (2011) 1.33
Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. J Med Chem (2004) 1.31
Virtual Screening with AutoDock: Theory and Practice. Expert Opin Drug Discov (2010) 1.30
1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Chembiochem (2005) 1.27
Fragment-based screen against HIV protease. Chem Biol Drug Des (2010) 1.26
P450cam visits an open conformation in the absence of substrate. Biochemistry (2010) 1.24
Structural analysis of Siah1-Siah-interacting protein interactions and insights into the assembly of an E3 ligase multiprotein complex. J Biol Chem (2005) 1.23
Probing molecular docking in a charged model binding site. J Mol Biol (2006) 1.17
Small-molecule library screening by docking with PyRx. Methods Mol Biol (2015) 1.17
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol (2004) 1.16
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics. J Comput Aided Mol Des (2010) 1.14
Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors. Chembiochem (2003) 1.13
Redox-based probes for protein tyrosine phosphatases. Angew Chem Int Ed Engl (2011) 1.13
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis. Proteins (2003) 1.11
The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis. J Mol Biol (2004) 1.10
Promoting a structural view of biology for varied audiences: an overview of RCSB PDB resources and experiences. J Appl Crystallogr (2010) 1.09
A molecular link between the active component of marijuana and Alzheimer's disease pathology. Mol Pharm (2006) 1.09
A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking. J Med Chem (2012) 1.08
Artificial protein cavities as specific ligand-binding templates: characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein. J Mol Biol (2002) 1.08
Adaptive Accelerated Molecular Dynamics (Ad-AMD) Revealing the Molecular Plasticity of P450cam. J Phys Chem Lett (2011) 1.07
Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett (2005) 1.05
Three clusters of conformational states in p450cam reveal a multistep pathway for closing of the substrate access channel. Biochemistry (2011) 1.05
Automated prediction of ligand-binding sites in proteins. Proteins (2008) 1.05
Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid. Biochemistry (2003) 1.05
Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires. J Mol Biol (2004) 1.04
The serine-rich domain from Crk-associated substrate (p130cas) is a four-helix bundle. J Biol Chem (2005) 1.03
Rapid and accurate prediction and scoring of water molecules in protein binding sites. PLoS One (2012) 1.02
p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. J Mol Biol (2009) 1.00
Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes. Biochemistry (2008) 1.00
Blind prediction of HIV integrase binding from the SAMPL4 challenge. J Comput Aided Mol Des (2014) 0.99
A dynamic model of HIV integrase inhibition and drug resistance. J Mol Biol (2010) 0.99
Discovery of protein phosphatase 2C inhibitors by virtual screening. J Med Chem (2006) 0.98
Freely available conformer generation methods: how good are they? J Chem Inf Model (2012) 0.98
Structure-based virtual screening and biological evaluation of Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase inhibitors. J Med Chem (2008) 0.97
Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases. J Virol (2003) 0.97
Virtual screening of integrase inhibitors by large scale binding free energy calculations: the SAMPL4 challenge. J Comput Aided Mol Des (2014) 0.96
Antibacterial and antifungal activity of sulfur-containing compounds from Petiveria alliacea L. J Ethnopharmacol (2005) 0.95
Small molecule regulation of protein conformation by binding in the Flap of HIV protease. ACS Chem Biol (2013) 0.94
The conformation of P450cam in complex with putidaredoxin is dependent on oxidation state. J Am Chem Soc (2013) 0.94
Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. J Mol Biol (2005) 0.93
S-Substituted cysteine derivatives and thiosulfinate formation in Petiveria alliacea-part II. Phytochemistry (2002) 0.93
Fluorescent probes for cytochrome p450 structural characterization and inhibitor screening. J Am Chem Soc (2002) 0.92
Excision of a proposed electron transfer pathway in cytochrome c peroxidase and its replacement by a ligand-binding channel. Protein Sci (2002) 0.92
Computational docking of biomolecular complexes with AutoDock. Cold Spring Harb Protoc (2009) 0.91
Defining HIV-1 protease substrate selectivity. Curr Drug Targets Infect Disord (2002) 0.91
Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds. PLoS One (2012) 0.91
Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport. Bioorg Med Chem (2010) 0.90
Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function. Mol Pharmacol (2009) 0.90
Protein flexibility in virtual screening: the BACE-1 case study. J Chem Inf Model (2012) 0.90
Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library. Biochemistry (2005) 0.90
Model of the alphaLbeta2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity. Proteins (2002) 0.89
Replacement of the axial histidine heme ligand with cysteine in nitrophorin 1: spectroscopic and crystallographic characterization. J Biol Inorg Chem (2008) 0.89
Double electron-electron resonance shows cytochrome P450cam undergoes a conformational change in solution upon binding substrate. Proc Natl Acad Sci U S A (2012) 0.89
Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders. J Am Chem Soc (2009) 0.89
The lachrymatory principle of Petiveria alliacea. Phytochemistry (2003) 0.88
Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides. Mol Biosyst (2007) 0.88
Crystallographic fragment-based drug discovery: use of a brominated fragment library targeting HIV protease. Chem Biol Drug Des (2013) 0.88
Roles for ordered and bulk solvent in ligand recognition and docking in two related cavities. PLoS One (2013) 0.88